TODD STRATEGY GROUP

Lobbying for ELI LILLY AND COMPANY · American pharmaceutical company.

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $80,000.00 income · posted Jan 20, 2026

Lobbying activity 2

Health Issues

Alzheimer's Disease. Anti Obesity Medication.

Medicare/Medicaid

Medicare/Medicaid Coverage and Reimbursement. PDUFA. 340B Program.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.